奥泰生物: 第三届监事会第十四次会议决议公告

Meeting Overview - The third supervisory board meeting of Hangzhou Aotai Biotechnology Co., Ltd. was held on August 8, 2025, with a legal and valid resolution [1] Adjustment of Stock Incentive Plan - The supervisory board approved the adjustment of the grant price for the 2022 Restricted Stock Incentive Plan, in compliance with relevant laws and regulations, ensuring no harm to the company and all shareholders [2][3] - The voting results for the proposal showed 3 votes in favor, 0 against, and 0 abstentions [2] Vesting Conditions - The vesting conditions for the first grant of the third vesting period and the reserved grant of the second vesting period have been met, allowing 94 eligible incentive recipients to vest a total of 409,472 shares, and 18 reserved recipients to vest 29,418 shares [2][3] - The voting results for this proposal also showed 3 votes in favor, 0 against, and 0 abstentions [3] Cancellation of Stock Grants - Due to the departure of 3 incentive recipients, a total of 6,177 shares of unvested restricted stock will be canceled, in accordance with relevant laws and the 2022 Incentive Plan [3] - The voting results for the cancellation proposal were 3 votes in favor, 0 against, and 0 abstentions [3]